• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经氟丙烷增强对比超声对钆塞酸增强 MRI 肝胆期低信号结节而动脉期无高增强特征的描述。

Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.

机构信息

Department of Radiology, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea.

Department of Radiology, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea.

出版信息

Abdom Radiol (NY). 2023 Jul;48(7):2321-2330. doi: 10.1007/s00261-023-03901-5. Epub 2023 Apr 25.

DOI:10.1007/s00261-023-03901-5
PMID:37097451
Abstract

PURPOSE

Hepatobiliary phase (HBP) hypointense nodules without arterial phase hyperenhancement (APHE) on gadoxetic acid-enhanced MRI (GA-MRI) may be nonmalignant cirrhosis-associated nodules or hepatocellular carcinomas (HCCs). We aimed to characterize HBP hypointense nodules without APHE on GA-MRI by performing contrast-enhanced ultrasound using perfluorobutane (PFB-CEUS).

METHODS

In this prospective, single-center study, participants at high-risk of HCC having HBP hypointense nodules without APHE at GA-MRI were enrolled. All participants underwent PFB-CEUS; if APHE and late, mild washout or washout in the Kupffer phase were present, the diagnosis of HCC was established according to the v2022 Korean guidelines. The reference standard consisted of histopathology or imaging. The sensitivity, specificity, and positive/negative predictive values of PFB-CEUS for detecting HCC were calculated. Associations between clinical/imaging features and the diagnosis of HCC were evaluated with logistic regression analyses.

RESULTS

In total, 67 participants (age, 67.0 years ± 8.4; 56 men) with 67 HBP hypointense nodules without APHE (median size, 1.5 cm [range, 1.0-3.0 cm]) were included. The prevalence of HCC was 11.9% (8/67). The sensitivity, specificity, and positive and negative predictive values of PFB-CEUS for detecting HCC were 12.5%(1/8), 96.6%(57/59), 33.3%(1/3) and 89.1%(57/64), respectively. Mild-moderate T2 hyperintensity on GA-MRI (odds ratio, 5.756; P = 0.042) and washout in the Kupffer phase on PFB-CEUS (odds ratio, 5.828; P = 0.048) were independently associated with HCC.

CONCLUSION

Among HBP hypointense nodules without APHE, PFB-CEUS was specific for detecting HCC, which had a low prevalence. Mild-moderate T2 hyperintensity on GA-MRI and washout in the Kupffer phase on PFB-CEUS may be useful to detect HCC in those nodules.

摘要

目的

在钆塞酸增强磁共振成像(GA-MRI)上,肝胆期(HBP)低信号结节且无动脉期增强(APHE)可能是非恶性肝硬化相关结节或肝细胞癌(HCC)。我们旨在通过使用全氟丁烷(PFB-CEUS)来对 GA-MRI 上 HBP 低信号且无 APHE 的结节进行特征描述。

方法

在这项前瞻性、单中心研究中,纳入了在 GA-MRI 上具有 HBP 低信号且无 APHE 的 HCC 高危人群。所有参与者均接受 PFB-CEUS 检查;如果存在 APHE 和晚期轻度洗脱或库普弗期洗脱,则根据 2022 年韩国指南诊断为 HCC。参考标准包括组织病理学或影像学。计算 PFB-CEUS 检测 HCC 的敏感性、特异性、阳性/阴性预测值。采用逻辑回归分析评估临床/影像学特征与 HCC 诊断之间的关联。

结果

共有 67 名(年龄 67.0±8.4 岁,男性 56 名)参与者,其 67 个 HBP 低信号且无 APHE 的结节(中位数大小为 1.5cm[范围,1.0-3.0cm])被纳入研究。HCC 的患病率为 11.9%(8/67)。PFB-CEUS 检测 HCC 的敏感性、特异性、阳性预测值和阴性预测值分别为 12.5%(8/8)、96.6%(57/59)、33.3%(1/3)和 89.1%(57/64)。GA-MRI 上的轻度至中度 T2 高信号(优势比,5.756;P=0.042)和 PFB-CEUS 上的库普弗期洗脱(优势比,5.828;P=0.048)与 HCC 独立相关。

结论

在 HBP 低信号且无 APHE 的结节中,PFB-CEUS 对 HCC 的检测具有特异性,但 HCC 的患病率较低。GA-MRI 上的轻度至中度 T2 高信号和 PFB-CEUS 上的库普弗期洗脱可能有助于检测这些结节中的 HCC。

相似文献

1
Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.经氟丙烷增强对比超声对钆塞酸增强 MRI 肝胆期低信号结节而动脉期无高增强特征的描述。
Abdom Radiol (NY). 2023 Jul;48(7):2321-2330. doi: 10.1007/s00261-023-03901-5. Epub 2023 Apr 25.
2
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.钆塞酸增强 MRI 肝胆期低信号结节无动脉期强化的放射-病理对照:多中心研究。
Radiology. 2020 Aug;296(2):335-345. doi: 10.1148/radiol.2020192275. Epub 2020 Jun 2.
3
Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.钆塞酸增强 MRI 肝胆期低信号结节无动脉期强化的高血管化转变:监测队列的长期随访。
Eur Radiol. 2022 Aug;32(8):5064-5074. doi: 10.1007/s00330-022-08623-8. Epub 2022 Feb 28.
4
Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.对比增强超声联合全氟丁烷在肝细胞癌诊断中的应用:成像相和诊断标准的比较。
AJR Am J Roentgenol. 2024 Feb;222(2):e2330156. doi: 10.2214/AJR.23.30156. Epub 2023 Nov 22.
5
Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.肝胆期低信号结节且无动脉期强化:它们在消融或手术后有 HCC 复发的风险吗?系统评价和荟萃分析。
Eur Radiol. 2020 Mar;30(3):1624-1633. doi: 10.1007/s00330-019-06499-9. Epub 2019 Nov 27.
6
Risk Factors for Hypervascularization in Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement: A Systematic Review and Meta-analysis.肝胆期低信号结节无动脉期强化的高血管化风险因素:系统评价和荟萃分析。
Acad Radiol. 2022 Feb;29(2):198-210. doi: 10.1016/j.acra.2020.08.031. Epub 2020 Sep 20.
7
Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.超声造影联合六氟化硫微泡与全氟丁烷微泡在高危人群肝细胞癌诊断中的应用。
Radiology. 2020 Oct;297(1):108-116. doi: 10.1148/radiol.2020200115. Epub 2020 Aug 4.
8
Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.肝胆期呈低血供低信号结节内高信号结节:转归及高血供转化率。
Eur J Radiol. 2019 Nov;120:108689. doi: 10.1016/j.ejrad.2019.108689. Epub 2019 Sep 20.
9
Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.含氟丁烷增强超声造影的 Kupffer 期成像:提高肝细胞癌的诊断灵敏度。
Eur Radiol. 2022 Dec;32(12):8507-8517. doi: 10.1007/s00330-022-08900-6. Epub 2022 Jun 16.
10
Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.使用标准化的超声造影(CEUS)观察肝细胞癌的洗脱现象,包括延长的晚期观察——来自前瞻性多中心 DEGUM 研究的真实世界数据。
Clin Hemorheol Microcirc. 2023;84(4):413-424. doi: 10.3233/CH-231740.

引用本文的文献

1
Long-term outcomes of indeterminate focal hepatic observations less than 20 mm followed up with gadoxetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-MRI).钆塞酸二钠增强磁共振成像(Gd-EOB-DTPA-MRI)随访观察小于20mm的肝脏局灶性病变的长期结果
J Gastrointest Oncol. 2025 Jun 30;16(3):1078-1091. doi: 10.21037/jgo-2025-302. Epub 2025 Jun 27.

本文引用的文献

1
Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.第八届国际肝脏磁共振成像论坛共识报告。
Eur Radiol. 2020 Jan;30(1):370-382. doi: 10.1007/s00330-019-06369-4. Epub 2019 Aug 5.
2
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理:美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
3
Contrast-enhanced ultrasound of malignant liver lesions.
恶性肝脏病变的超声造影。
Abdom Radiol (NY). 2018 Apr;43(4):819-847. doi: 10.1007/s00261-017-1360-8.
4
Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.钆塞酸二钠增强磁共振成像用于肝细胞癌的特征描述:一项系统评价和荟萃分析。
J Magn Reson Imaging. 2017 Jan;45(1):281-290. doi: 10.1002/jmri.25345. Epub 2016 Jun 14.
5
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.肝细胞癌的CT与MR成像诊断及分期:第一部分。发生、生长与扩散:关键病理及成像要点
Radiology. 2014 Sep;272(3):635-54. doi: 10.1148/radiol.14132361.
6
Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.患者内匹配队列研究:钆塞酸二钠与钆贝葡胺在肝脏磁共振成像中动脉期呼吸运动相关伪影的比较。
Radiology. 2014 Jul;272(1):123-31. doi: 10.1148/radiol.14132269. Epub 2014 Mar 8.
7
Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.呼吸运动伪影对钆塞酸二钠肝动脉期成像的影响:采用多次动脉期采集进行检查恢复。
Radiology. 2014 May;271(2):426-34. doi: 10.1148/radiol.13131988. Epub 2014 Jan 21.
8
Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.对比超声造影剂 Sonazoid 增强的肝库普弗期成像与钆塞酸二钠增强磁共振成像在肝细胞癌中的应用,并与组织学分级相关。
J Ultrasound Med. 2012 Apr;31(4):529-38. doi: 10.7863/jum.2012.31.4.529.
9
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.肝胆特异性磁共振对比剂:在肝脏和胆道成像中的作用。
Radiographics. 2009 Oct;29(6):1725-48. doi: 10.1148/rg.296095515.
10
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.库普弗细胞对超声造影剂微泡的吞噬作用。
Ultrasound Med Biol. 2007 Feb;33(2):318-25. doi: 10.1016/j.ultrasmedbio.2006.08.008.